Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making the high-throughput machines more attractive to smaller laboratories. For its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced that it will present updates on several key innovations in whole-genome sequencing, proteomics, and ...

Proteomics enables the observation of direct cellular function to gain insights on protein-driven disease traits. (Image Credits: Pixabay) Illumina, Inc. on Monday announced that it will present ...

In a mainstage presentation on November 6, Steve Barnard, PhD, chief technology officer, will reveal new details on the company's constellation mapped read technology, originally announced in the ...

Illumina stock (NASDAQ: ILMN) saw a 6% rise on Wednesday, July 10, faring better than its peer — Mettler-Toledo stock (NYSE:MTD) – up 1%. The rise in ILMN stock can primarily be attributed to the ...

When Illumina (ILMN) announced its acquisition of Fluent BioSciences, it did not say how much it shelled out for the privately held single-cell technology developer in a deal that catapulted the ...

INDIA - 2023/12/16: In this photo illustration, the Illumina logo is seen displayed on a mobile phone screen. (Photo Illustration by Idrees Abbas/SOPA Images/LightRocket via Getty Images) Given the ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced that it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell ...

Illumina, Inc. ILMN recently acquired Fluent BioSciences, a developer of innovative single-cell technology. This strategic acquisition marks a significant step in Illumina's expansion within the ...